- Home
- DBI vs CRBU Comparison
DBI vs CRBU Comparison
Compare DBI & CRBU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DBI
- CRBU
- Stock Information
- Founded
- DBI 1991
- CRBU 2011
- Country
- DBI United States
- CRBU United States
- Employees
- DBI N/A
- CRBU N/A
- Industry
- DBI Clothing/Shoe/Accessory Stores
- CRBU Medicinal Chemicals and Botanical Products
- Sector
- DBI Consumer Discretionary
- CRBU Health Care
- Exchange
- DBI Nasdaq
- CRBU Nasdaq
- Market Cap
- DBI 292.2M
- CRBU 236.3M
- IPO Year
- DBI 1991
- CRBU 2021
- Fundamental
- Price
- DBI $5.65
- CRBU $1.79
- Analyst Decision
- DBI Hold
- CRBU Strong Buy
- Analyst Count
- DBI 2
- CRBU 4
- Target Price
- DBI $5.75
- CRBU $12.00
- AVG Volume (30 Days)
- DBI 2.3M
- CRBU 1.5M
- Earning Date
- DBI 12-10-2024
- CRBU 11-06-2024
- Dividend Yield
- DBI 3.57%
- CRBU N/A
- EPS Growth
- DBI N/A
- CRBU N/A
- EPS
- DBI N/A
- CRBU N/A
- Revenue
- DBI $3,050,038,000.00
- CRBU $11,475,000.00
- Revenue This Year
- DBI $0.78
- CRBU N/A
- Revenue Next Year
- DBI $3.19
- CRBU N/A
- P/E Ratio
- DBI N/A
- CRBU N/A
- Revenue Growth
- DBI N/A
- CRBU N/A
- 52 Week Low
- DBI $4.36
- CRBU $1.50
- 52 Week High
- DBI $11.57
- CRBU $8.33
- Technical
- Relative Strength Index (RSI)
- DBI 50.89
- CRBU 37.96
- Support Level
- DBI $5.28
- CRBU $1.72
- Resistance Level
- DBI $6.21
- CRBU $1.97
- Average True Range (ATR)
- DBI 0.51
- CRBU 0.14
- MACD
- DBI 0.02
- CRBU -0.03
- Stochastic Oscillator
- DBI 57.05
- CRBU 9.12
About DBI Designer Brands Inc.
Designer Brands Inc is a designer, producer, and retailer of footwear and accessories. The company operates in three reportable segments: the U.S. Retail segment, the Canada Retail segment, and the Brand Portfolio segment. The U.S. Retail segment operates the DSW Designer Shoe Warehouse banner through its direct-to-consumer U.S. stores and e-commerce site. The Canada Retail segment operates The Shoe Company and DSW banners through its direct-to-consumer Canada stores and e-commerce sites. The Brand Portfolio segment earns revenue from the sale of wholesale products to retailers, commissions for serving retailers as the design and buying agent for products under private labels, and the sale of branded products through its direct-to-consumer e-commerce sites.
About CRBU Caribou Biosciences Inc.
Caribou Biosciences Inc is a clinical-stage Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) biopharmaceutical company dedicated to transforming the lives of patients with devastating diseases by applying its novel CRISPR platform, CRISPR hybrid RNA-DNA (chRDNA), toward the development of next-generation, genome-edited cell therapies. The company operates and manage business as one reportable operating segment, which is the business of developing a pipeline of allogeneic CAR-T and CAR-NK cell therapies.